Condition: Coronary Artery Disease · Acute Myocardial Infarction · Ventricular Fibrillation · Sponsor: Rigshospitalet, Denmark
DanICD is a randomized, controlled study to with the aim to assess whether there is a benefit of ICD-implantation in patients with coronary artery disease (including acute myocardial infarction), who survive cardiac arrest due to ventricular fibrillation/sustained ventricular tachycardia and undergo revascularization and with an LVEF above 35%.
This description comes directly from the study's public registry record.
Reza Jabbari, MD, PhD · +4535455380 · reza.jabbari.02@regionh.dk
Thomas Engstrøm, MD, PhD, DMSc · +4535458444 · thomas.engstroem@regionh.dk
Always discuss trial participation with your own doctor first.
| Copenhagen University Hospital, Rigshospitalet | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04576130